Association of KLF14 rs4731702 gene polymorphism with metabolic phenotype in young patients with type 1 diabetes
Diabetes, Obesity and Metabolism · 2024
DOI: 10.1111/dom.15707 ↗Kurz gefasst
Fachartikel in der Zeitschrift Diabetes, Obesity and Metabolism, 2024. Verfasst von Monika Ryba-Stanisławowska und 2 weiteren Autor:innen. Beteiligte Einrichtung: Department of Medical Immunology, Faculty of Medicine, Medical University of Gdańsk, Gdańsk, Poland. Hauptthemen laut MEDLINE: Diabetes Mellitus, Type 1, Kruppel-Like Transcription Factors, Polymorphism, Single Nucleotide. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 39 Literaturangaben. Gefördert von: the State Committee for Scientific Research ST49 (Medical University of Gdańsk), Gdański Uniwersytet Medyczny.
Themen: Diabetes mellitus
Abstract (Originalsprache)
Aim
To explore the potential association between the KLF14 rs4731702 polymorphism and metabolic syndrome traits among patients diagnosed with type 1 diabetes (T1D).
Methods
The study group included 350 patients with T1D and 250 healthy control subjects. The analysis focused on the genotyping of KLF14 rs4731702 single nucleotide polymorphism (SNP), as well as evaluating serum concentrations of inflammatory markers, blood pressure, lipid profiles, and the quantitative status of CD4 + CD25highFOXP3+ T cells.
Results
Patients with T1D carrying the T allele of KLF14 rs4731702 SNP had higher high‐density lipoprotein cholesterol, lower low‐density lipoprotein cholesterol, as well as lower glycated haemoglobin and serum concentration of proinflammatory markers than C allele carriers. They also developed hypertension less often than carriers of the C allele. The analysis of CD4 + CD25highFOXP3+ regulatory T‐cell status based on KLF14 genotype showed that, in T1D patients, those with the TT genotype had the highest frequency of these cells compared to carriers of the CC and CT genotypes.
Conclusion
Our study suggests that the T allele of the KLF14 rs4731702 SNP might confer a protective effect against the development of obesity, hypertension, dyslipidaemia, and chronic inflammatory state in patients diagnosed with T1D.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Medical Immunology, Faculty of Medicine, Medical University of Gdańsk, Gdańsk, Poland.
- Chair & Clinics of Paediatrics, Diabetology and Endocrinology, Faculty of Medicine, Medical University of Gdańsk, Gdańsk, Poland.
ORCID-Profile: Monika Ryba-Stanisławowska, Bartosz Słomiński
Förderung
- the State Committee for Scientific Research ST49 (Medical University of Gdańsk)
- Gdański Uniwersytet Medyczny
Zitieren
APA
Ryba-Stanisławowska, M., Słomiński, B., & Myśliwiec, M. (2024). Association of KLF14 rs4731702 gene polymorphism with metabolic phenotype in young patients with type 1 diabetes. Diabetes, Obesity and Metabolism. https://doi.org/10.1111/dom.15707
Vancouver
Ryba-Stanisławowska M, Słomiński B, Myśliwiec M. Association of KLF14 rs4731702 gene polymorphism with metabolic phenotype in young patients with type 1 diabetes. Diabetes, Obesity and Metabolism. 2024. doi:10.1111/dom.15707
BibTeX
@article{RybaStanisawowska2024,
author = {Ryba-Stanisławowska, Monika and Słomiński, Bartosz and Myśliwiec, Małgorzata},
title = {Association of KLF14 rs4731702 gene polymorphism with metabolic phenotype in young patients with type 1 diabetes},
journal = {Diabetes, Obesity and Metabolism},
year = {2024},
doi = {10.1111/dom.15707}
}
EUVIMED